Bio-Techne Corp
TECH: XNAS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$23.00 | Plkzbg | Sdwvtzzyn |
Bio-Techne Leads Key Proteomic Reagent Markets
Business Strategy and Outlook
Narrow moat Bio-Techne is a market leader in proteins, immunoassays, clinical diagnostic controls, and other reagents that are crucial for the academic, biopharmaceutical, and diagnostic markets.